Elicit: Standard of Care in Acute Kidney Injury (public)
What is the standard of care for acute kidney injury?
Acute kidney injury standard care includes delayed rather than preemptive renal replacement therapy initiation, standard dosing targets, modality selection based on patient hemodynamics and resources, and care bundles with early nephrology consultation.
Abstract
Acute kidney injury care relies on initiating renal replacement therapy (RRT) only when conventional indications are present rather than preemptively. Large randomized trials and meta-analyses note that early or accelerated initiation does not reduce 90‐day mortality and may lead to more adverse events, as many patients in delayed arms avoid RRT altogether. Standard dosing targets provide outcomes similar to intensified regimens, and modality choice—whether continuous therapies, intermittent hemodialysis, or peritoneal dialysis—is guided by patient hemodynamic status, local expertise, and resource availability (with peritoneal dialysis endorsed by the International Society for Peritoneal Dialysis). Additionally, care bundles aligned with best practice guidelines and early nephrology involvement improve process measures such as AKI recognition and documentation, with some studies reporting reductions in progression and rehospitalization.
Methods
We analyzed 40 sources from an initial pool of 1000, using 8 screening criteria. Each paper was reviewed for 6 key aspects that mattered most to the research question. More on methods.
Papers identified with Elicit search
n = 1000
Papers screened using: AKI Population, Standard Care Interventions, Clinical Outcomes, Study Design, Population and Setting, Treatment Focus, Primary AKI Focus, Human Studies
n = 1000
Papers screened out
n = 960
Papers included for extraction
n = 40
Screening
We screened in sources based on their abstracts that met these criteria:
- AKI Population: Does the study include patients diagnosed with acute kidney injury (AKI) as defined by established criteria (KDIGO, RIFLE, or AKIN)?
- Standard Care Interventions: Does the study examine therapeutic interventions, management strategies, or treatment protocols that are considered standard care for AKI (excluding experimental treatments not in established practice)?
- Clinical Outcomes: Does the study report clinical outcomes such as renal recovery, mortality, dialysis requirement, length of stay, or complications?
- Study Design: Is the study a randomized controlled trial, observational study (cohort, case-control), clinical practice guideline, systematic review, or meta-analysis?
- Population and Setting: Does the study include adult patients (≥18 years) in hospital or clinical settings?
- Treatment Focus: Does the study focus on treatment of established AKI rather than solely on prevention strategies?
- Primary AKI Focus: Does the study have AKI management as a primary focus rather than examining AKI only as a secondary outcome?
- Human Studies: Is this a human study (not in vitro or animal research)?
We considered all screening questions together and made a holistic judgement about whether to screen in each paper.
Data extraction
We asked a large language model to extract each data column below from each paper. We gave the model the extraction instructions shown below for each column.
- Study Design:
Specify the exact type of study design (e.g., randomized controlled trial, prospective cohort, retrospective cohort).
Look in the methods section for explicit description of study design.
If multiple design elements are present, list all relevant characteristics.
If design is not clearly stated, write “Not clearly reported”.
Setting and Context:
Describe the specific healthcare setting where the study was conducted.
Identify location (country, specific type of healthcare facility).
Note any unique contextual features that might impact acute kidney injury (AKI) management.
If multiple settings were involved, list all.
If setting is not clearly described, write “Not reported”.
Participant Population:
Describe the key characteristics of study participants:
Total number of participants.
Inclusion criteria for AKI.
Severity of AKI (using standard staging criteria).
Mean/median age.
Gender distribution.
Key comorbidities.
Intervention Details:
Describe the specific intervention for AKI management:
Detailed components of the intervention.
Who delivered the intervention.
Frequency and duration of intervention.
Any multidisciplinary team components.
Primary Outcomes:
List all primary outcomes measured:
Specify exact outcome measures.
Include statistical results (means, percentages, p-values).
Note measurement time points.
Risk of Bias Assessment:
Assess potential sources of bias:
- Randomization method (for RCTs).
- Blinding procedures.
- Loss to follow-up rates.
- Potential conflicts of interest.
Results
Characteristics of Included Studies
| Study | Study Focus | Population | Intervention/Topic | Key Outcomes Measured | Full text retrieved |
|---|---|---|---|---|---|
| Sohaney et al., 2020 | Timing of Kidney Replacement Therapy (KRT) initiation in Acute Kidney Injury (AKI) | 3,019 critically ill adults with KDIGO stage 2/3 AKI | Accelerated vs. standard KRT initiation | 90-day mortality, KRT dependence, adverse events | No |
| Kolhe et al., 2015 | AKI care bundle implementation | 2,297 patients, 2,500 AKI episodes | AKI care bundle with electronic alert | In-hospital case fatality, AKI progression | Yes |
| Aitken et al., 2013 | Quality of AKI care | 1,577 hospital admissions | Standard care | Mortality, AKI recognition, documentation | No |
| Landoni et al., 2013 | Interventions affecting AKI mortality | >300 physicians (survey); literature review | Systematic review and survey | Mortality, intervention-practice gap | No |
| STARRT-AKI Investigators, 2020 | Timing of Renal Replacement Therapy (RRT) in severe AKI | 3,019 ICU patients with KDIGO stage 2/3 AKI | Accelerated vs. standard RRT | 90-day mortality, RRT dependence, adverse events | Yes |
| Kolhe et al., 2016 | AKI care bundle compliance | 3,518 patients, 3,717 AKI episodes | AKI care bundle (fluid, drugs, nephrotoxins) | In-hospital case fatality, AKI progression | No |
| Thanapongsatorn et al., 2021 | Multidisciplinary post-AKI care | 98 AKI stage 2-3 survivors | Multidisciplinary Care Team (MDCT) post-AKI care vs. standard | Feasibility, estimated Glomerular Filtration Rate (eGFR), albuminuria, Blood Pressure (BP) control | Yes |
| Graham-Brown et al., 2024 | National audit of AKI care | 989 AKI stage 2/3 episodes | Standard care | 30-day mortality, care standard completion | No |
| Jeong et al., 2021 | Timing of RRT in ICU AKI | No mention found | Early vs. delayed RRT | Survival, RRT dependence | No |
| Wang et al., 2017 | RRT intensity and renal recovery | 3,682 ICU AKI patients | High vs. standard RRT intensity | Mortality, RRT dependence | No |
Effects
Renal Replacement Therapy Modality Selection
- Most studies we reviewed that addressed renal replacement therapy modality (such as continuous renal replacement therapy, intermittent hemodialysis, peritoneal dialysis, or extended dialysis) reported no clear difference in mortality or renal recovery for the general acute kidney injury population in the intensive care unit. These findings are based on meta-analyses, randomized controlled trials, and guidelines.
- The International Society for Peritoneal Dialysis guideline supports the use of peritoneal dialysis as a suitable modality in all settings, with specific recommendations for catheter type, dosing, and monitoring.
- Observational data and reviews reported that local expertise, resource availability, and patient hemodynamic status often drive modality choice.
Timing of Renal Replacement Therapy Initiation
- Multiple large randomized controlled trials and meta-analyses reported that early or accelerated initiation of renal replacement therapy in critically ill acute kidney injury did not reduce mortality compared to standard or delayed strategies.
- A significant proportion of patients in delayed arms never required renal replacement therapy, suggesting that early initiation may lead to unnecessary treatment.
- Some subgroup analyses reported possible benefit, but findings were inconsistent.
Renal Replacement Therapy Dosing and Adequacy Targets
| Study | Renal Replacement Therapy Modality | Dosing Target | Clinical Context | Evidence Level |
|---|---|---|---|---|
| Wang et al., 2017 | Continuous renal replacement therapy, intermittent hemodialysis | High vs. standard intensity | Intensive care unit acute kidney injury | Meta-analysis of randomized controlled trials |
| Palevsky et al., 2008 | Intermittent hemodialysis, continuous renal replacement therapy | Intensive vs. less-intensive | Critically ill acute kidney injury | Randomized controlled trial |
| Van Wert et al., 2010 | Continuous renal replacement therapy, intermittent hemodialysis, sustained low-efficiency dialysis | High vs. standard dose | Critical illness | Meta-analysis of randomized controlled trials |
| Faulhaber-Walter et al., 2009 | Extended dialysis | Intensified vs. standard | Intensive care unit acute kidney injury | Randomized controlled trial |
| Parapiboon and Jamratpan, 2017 | Peritoneal dialysis | Intensive vs. minimal | Acute kidney injury | Randomized controlled trial |
| Cullis et al., 2020 | Peritoneal dialysis | Kt/V targets | Acute kidney injury (guideline) | Guideline |
Early Nephrology Intervention and Monitoring
- Several studies reported that early nephrology involvement, whether through early consults, multidisciplinary teams, or structured post-acute kidney injury follow-up, was associated with improved process measures, reduced acute kidney injury progression, and possibly lower mortality or rehospitalization.
- The evidence was mixed, with some studies reporting no significant reduction in major adverse kidney events.
Strategies for Renal Recovery Optimization
- Care bundles based on Kidney Disease: Improving Global Outcomes or similar guidelines, often incorporating electronic alerts and standardized protocols, were reported to be associated with reduced mortality, acute kidney injury progression, and need for renal replacement therapy in both observational studies and meta-analyses.
- Bundles that included biomarker-based risk stratification may further improve outcomes.
- National audits and registry studies reported persistent gaps in acute kidney injury recognition, documentation, and adherence to best practices.
Summary
The included studies reported that the standard of care for acute kidney injury includes:
- Initiation of renal replacement therapy for conventional indications, not preemptively, in critically ill acute kidney injury.
- Use of standard renal replacement therapy dosing targets; higher intensity did not improve outcomes in the studies reviewed.
- Modality selection based on patient context, with peritoneal dialysis as a viable option according to International Society for Peritoneal Dialysis guidelines.
- Implementation of care bundles and early nephrology involvement, which improved process measures and may reduce adverse outcomes.
- Ongoing quality improvement efforts are needed to address persistent gaps in acute kidney injury recognition and management.